相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Low-dose methotrexate may preserve a stronger antileukemic effect than that of cyclosporine after modified donor lymphocyte infusion in unmanipulated haploidentical HSCT
Chen-Hua Yan et al.
CLINICAL TRANSPLANTATION (2015)
Outcome of Donor Lymphocyte Infusion after T Cell-depleted Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndromes
Pramila Krishnamurthy et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
Donor lymphocyte infusions for relapse after allogeneic transplantation. When, if and for whom?
Ying-Jun Chang et al.
BLOOD REVIEWS (2013)
Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
P. Rujkijyanont et al.
BLOOD CANCER JOURNAL (2013)
In vivo T-cell depletion with pretransplant low-dose antithymocyte globulin is associated with reduced transplant-related mortality and improved clinical outcome in patients receiving allogeneic hematopoietic stem cell transplantation from unrelated and partially matched related donors
Alessandro Busca et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation
Claire Roddie et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2011)
Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies
Didier Blaise et al.
EXPERIMENTAL HEMATOLOGY (2010)
Defining the Intensity of Conditioning Regimens: Working Definitions
Andrea Bacigalupo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect
X-J Huang et al.
BONE MARROW TRANSPLANTATION (2009)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes
Zi Yi Lim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
The impact of chimerism patterns and predonor leukocyte infusion lymphopenia on survival following T cell-depleted reduced intensity conditioned transplants
Bronwen E. Shaw et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation
Xiao-Jun Huang et al.
HAEMATOLOGICA (2007)
Targeting the activation-induced antigen CD137 can selectively deplete alloreactive T cells from antileukemic and antitumor donor T-cell lines
Thomas C. Wehler et al.
BLOOD (2007)
A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation
DL Porter et al.
BLOOD (2006)
Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemia
XJ Huang et al.
LEUKEMIA (2006)
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
S Tauro et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report
AH Filipovich et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome
K van Besien et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses
KS Peggs et al.
BLOOD (2004)
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning
AYL Ho et al.
BLOOD (2004)
Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for myeloid malignancies in patients older than 55 years
R Wong et al.
BLOOD (2003)
Impact of prophylactic donor leukocyte infusions on mixed chimerism, graft-versus-host disease, and antitumor response in patients with advanced hematologic malignancies treated with nonmyeloablative conditioning and allogeneic bone marrow transplantation
BR Dey et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation
DI Marks et al.
BLOOD (2002)
Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens
JE Parker et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantation
N Schaap et al.
LEUKEMIA (2002)
分享论文
